235 related articles for article (PubMed ID: 21078800)
1. Radionuclide imaging of angiotensin II type 1 receptor upregulation after myocardial ischemia-reperfusion injury.
Higuchi T; Fukushima K; Xia J; Mathews WB; Lautamäki R; Bravo PE; Javadi MS; Dannals RF; Szabo Z; Bengel FM
J Nucl Med; 2010 Dec; 51(12):1956-61. PubMed ID: 21078800
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of angiotensin II type 2 receptor and limitation of myocardial stunning by angiotensin II type 1 receptor blockers during reperfused myocardial infarction in the rat.
Jugdutt BI; Menon V
J Cardiovasc Pharmacol Ther; 2003 Sep; 8(3):217-26. PubMed ID: 14506547
[TBL] [Abstract][Full Text] [Related]
3. AT1 receptor blockade limits myocardial injury and upregulates AT2 receptors during reperfused myocardial infarction.
Jugdutt BI; Menon V
Mol Cell Biochem; 2004 May; 260(1-2):111-8. PubMed ID: 15228092
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 4th communication: improvement of heart failure of rats with myocardial infarction by valasartan.
Hayashi N; Fujimura Y; Yamamoto S; Kometani M; Nakao K
Arzneimittelforschung; 1997 May; 47(5):625-9. PubMed ID: 9205776
[TBL] [Abstract][Full Text] [Related]
5. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.
Burchill LJ; Velkoska E; Dean RG; Griggs K; Patel SK; Burrell LM
Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807
[TBL] [Abstract][Full Text] [Related]
6. Aliskiren reduces myocardial ischemia-reperfusion injury by a bradykinin B2 receptor- and angiotensin AT2 receptor-mediated mechanism.
Koid SS; Ziogas J; Campbell DJ
Hypertension; 2014 Apr; 63(4):768-73. PubMed ID: 24420538
[TBL] [Abstract][Full Text] [Related]
7. Valsartan-induced cardioprotection involves angiotensin II type 2 receptor upregulation in dog and rat models of in vivo reperfused myocardial infarction.
Jugdutt BI; Menon V
J Card Fail; 2004 Feb; 10(1):74-82. PubMed ID: 14966778
[TBL] [Abstract][Full Text] [Related]
8. Molecular hybrid positron emission tomography/computed tomography imaging of cardiac angiotensin II type 1 receptors.
Fukushima K; Bravo PE; Higuchi T; Schuleri KH; Lin X; Abraham MR; Xia J; Mathews WB; Dannals RF; Lardo AC; Szabo Z; Bengel FM
J Am Coll Cardiol; 2012 Dec; 60(24):2527-34. PubMed ID: 23158533
[TBL] [Abstract][Full Text] [Related]
9. Combined angiotensin II AT1-receptor blockade and angiotensin I-converting enzyme inhibition on survival and cardiac remodeling in chronic heart failure in rats.
Richer C; Fornes P; Domergue V; De Gasparo M; Giudicelli JF
J Card Fail; 2001 Sep; 7(3):269-76. PubMed ID: 11561229
[TBL] [Abstract][Full Text] [Related]
10. Aliskiren and Valsartan reduce myocardial AT1 receptor expression and limit myocardial infarct size in diabetic mice.
Ye Y; Qian J; Castillo AC; Perez-Polo JR; Birnbaum Y
Cardiovasc Drugs Ther; 2011 Dec; 25(6):505-15. PubMed ID: 21987107
[TBL] [Abstract][Full Text] [Related]
11. Valsartan-induced cardioprotection involves angiotensin II type 2 receptor upregulation in isolated ischaemia and reperfused rat hearts.
Li KY; Zhang YJ
Acta Cardiol; 2015 Feb; 70(1):67-72. PubMed ID: 26137805
[TBL] [Abstract][Full Text] [Related]
12. Modulation of oxidative stress by enalapril and valsartan in adrenaline treated rats: a comparative study.
Huda S; Akhter N
Bangladesh Med Res Counc Bull; 2014 Apr; 40(1):25-30. PubMed ID: 26118169
[TBL] [Abstract][Full Text] [Related]
13. Enalapril protects against myocardial ischemia/reperfusion injury in a swine model of cardiac arrest and resuscitation.
Wang G; Zhang Q; Yuan W; Wu J; Li C
Int J Mol Med; 2016 Nov; 38(5):1463-1473. PubMed ID: 27633002
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme inhibition and angiotensin AT1 receptor blockade downregulate angiotensin-converting enzyme expression and attenuate renal injury in streptozotocin-induced diabetic rats.
Motawi TK; El-Maraghy SA; Senousy MA
J Biochem Mol Toxicol; 2013 Jul; 27(7):378-87. PubMed ID: 23733546
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II type 1 receptor-mediated upregulation of calcineurin activity underlies impairment of cardioprotective signaling in diabetic hearts.
Hotta H; Miura T; Miki T; Togashi N; Maeda T; Kim SJ; Tanno M; Yano T; Kuno A; Itoh T; Satoh T; Terashima Y; Ishikawa S; Shimamoto K
Circ Res; 2010 Jan; 106(1):129-32. PubMed ID: 19910577
[TBL] [Abstract][Full Text] [Related]
16. Valsartan attenuates oxidative stress and NF-κB activation and reduces myocardial apoptosis after ischemia and reperfusion.
Wu B; Lin R; Dai R; Chen C; Wu H; Hong M
Eur J Pharmacol; 2013 Apr; 705(1-3):140-7. PubMed ID: 23499691
[TBL] [Abstract][Full Text] [Related]
17. Targeting of endothelin receptors in the healthy and infarcted rat heart using the PET tracer 18F-FBzBMS.
Higuchi T; Rischpler C; Fukushima K; Isoda T; Xia J; Javadi MS; Szabo Z; Dannals RF; Mathews WB; Bengel FM
J Nucl Med; 2013 Feb; 54(2):277-82. PubMed ID: 23315664
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 1st communication: antihypertensive effects of valsartan in hypertensive models.
Yamamoto S; Hayashi N; Kometani M; Nakao K; Inukai T
Arzneimittelforschung; 1997 May; 47(5):604-12. PubMed ID: 9205773
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat.
Whaley-Connell AT; Chowdhury NA; Hayden MR; Stump CS; Habibi J; Wiedmeyer CE; Gallagher PE; Tallant EA; Cooper SA; Link CD; Ferrario C; Sowers JR
Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1308-14. PubMed ID: 16788142
[TBL] [Abstract][Full Text] [Related]
20. Aliskiren in combination with valsartan exerts synergistic protective effects against ventricular remodeling after myocardial infarction in mice.
Higashikuni Y; Takaoka M; Iwata H; Tanaka K; Hirata Y; Nagai R; Sata M
Hypertens Res; 2012 Jan; 35(1):62-9. PubMed ID: 21833001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
